Quince Therapeutics QNCX
NASDAQ QNCX
$33.93 +1.82 (+5.67%)
At close: Aug 21, 2026 · 4:00 PM EDT

Quince Therapeutics (QNCX) Current Leases (2019)

Quince Therapeutics (QNCX) posted quarterly Current Leases of $340000.0 for Q1 2019.

Quince Therapeutics (QNCX) Current Leases (2019) Analysis & Trends

Quince Therapeutics' Current Leases history runs 1 years deep, the most recent figure standing at $340000.0 for Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 21.95 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 45.93 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Quince Therapeutics 203.43 Mn 203.43 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2019 340,000.00